Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus
Sr. No. |
Title of the project |
Role |
Sanction No. |
Funding Agency |
Duration |
Funds sanctioned (Rs., Lakh) |
1 |
Design and Synthesis of Novel Agents for the Management of Rheumatoid Arthritis |
PI |
37-117/2009 (SR) |
University Grants Commission |
1/4/2010-31/3/2013 |
8.35 |
2 |
Design and Synthesis of Novel Agents for the Treatment of Rheumatoid Arthritis |
PI |
SR/FT/CS-100/2009 |
Department of Science and Technology |
1/9/2010-31/8/2013 |
19.03 |
3 |
Analysis of herbal extracts and formulations for antioxidant activity |
PI |
|
Vedic Life Sciences, Mumbai, India |
2006-07 |
0.5 |
4 |
Verifying the structural evidence for the presence of Sennosides |
PI |
|
Shashi Phytochemicals Limited, India |
2012 |
0.5 |
5 |
Design, synthesis, and biological evaluations of b- secretase inhibitors as anti-Alzheimer's agents |
Co-PI |
DST/INT/Pol/P-21/2016 |
DST Indo-Polish Joint Research Programme. Project No. DST/INT/Pol/P-21/2016. Indian PI: Dr. Ruchi Malik, Central Univ of Rajasthan and Polish PI: Prof. Slawomir Filipek, University of Warsaw, Warsaw, Poland |
7/6/2017-6/6/2020 |
19.84 |
6 |
DBT-BUILDER -University of Birla Institute of Technology and Science Pilani, Pilani Campus: Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome Editing |
Co-PI |
BT/INF/22/SP42545/2021 |
Department of Biotechnology |
24/9/2021-23/9/2026 |
901.8 |
7 |
Design, synthesis, and evaluation of novel dual inhibitors of Angiotensin-II type 1 receptor and Neprilysin for the treatment of diabetic cardiomyopathy |
PI |
CRG/2022/004698 |
Science and Engineering Research Board |
07/09/2023- 06/09/2026 |
33.02 |
8 |
Design, synthesis, and evaluation of novel dual inhibitors of dipeptidyl peptidase 4 (DPPIV) and Neprilysin for the treatment of diabetes |
PI |
IIRP-2023-6880 |
ICMR |
6/5/2024 to 5/5/2027 |
41.12 |
This website uses cookies or similar technologies, to enhance your browsing experience.